Sehar Timings Mar 29 - Ramazan 18

Lahore
LHR
04:36 AM
Karachi
KHI
05:12 AM
Islamabad
ISB
04:38 AM
Peshawar
PWR
04:42 AM
Quetta
QTA
05:07 AM

News

Brazil allows trials of Chinese vaccine to resume

November 11, 2020 09:16 PM


Brazil's national health regulator allowed clinical trials of a Chinese-developed Covid-19 vaccine to resume Wednesday, two days after suspending them in what critics called a decision tainted by politics.

The regulatory agency, Anvisa, said it had now received more details on the nature of the "adverse incident" that led it to halt trials of the CoronaVac vaccine, and had "sufficient information to allow vaccination to resume."

Far-right President Jair Bolsonaro, who has criticized CoronaVac as the vaccine "from that other country," had claimed the suspension as a victory.

However, public health officials said the incident that led to it -- a volunteer recipient's death, which police are investigating as a suicide -- had no connection with the vaccine.

CoronaVac has been caught up in a messy political battle in Brazil, where its most visible backer has been Sao Paulo Governor Joao Doria, a leading Bolsonaro opponent.

The president has thrown his support behind another vaccine, developed by Oxford University in Britain and the British-Swedish pharmaceutical firm AstraZeneca.

Bolsonaro, who has railed against CoronaVac as "Joao Doria's Chinese vaccine" and blocked the federal government from purchasing it, had claimed the regulatory decision as vindication.

"The president said this vaccine could never be mandatory. Chalk up another win for Jair Bolsonaro," he wrote Tuesday on Facebook, referring to himself in the third person.

Even as it reversed course, Anvisa stood by its decision, which it said was purely "technical," in a statement mainly devoted to defending the agency against criticism of political interference in the medical regulatory process.

It said the public health center coordinating the study in Brazil, the Butantan Institute, had not sent it the cause of death, independent safety review or a required incident report until Tuesday.

The decision "took into consideration the data known to the agency at the time," it said.

 

 



Most Read

  1. Man murders young sister by smothering her with pillow in Toba Tek Singh Man murders young sister by smothering her with pillow in Toba Tek Singh
  2. Aitchison College students, parents stage protest against principal’s resignation Aitchison College students, parents stage protest against principal’s resignation
  3. Five Chinese among six killed in Shangla suicide bombing Five Chinese among six killed in Shangla suicide bombing
  4. Sahiba meets her father for the first time Sahiba meets her father for the first time
  5. Maaz Safder regrets 4-year relationship with wife Saba Maaz Safder regrets 4-year relationship with wife Saba
  6. ‘Khaie's incredible ending receives rave reviews and big applause ‘Khaie's incredible ending receives rave reviews and big applause

Opinion

  1. IMEC to sabotage CPEC
    IMEC to sabotage CPEC

    By Dr Asif Channer

  2. 1947 TO FORM 47
    1947 TO FORM 47

    By Dr Asif Channer

  3. Beijing wants to further highlight industrial sector in its country and take scientific innovation to new heights....
    Beijing wants to further highlight industrial sector in its country and take scientific innovation to new heights....

    By Ali Ramay

  4. Global race: China will reduce its unnecessary expenses
    Global race: China will reduce its unnecessary expenses

    By Ali Ramay

  5. Channer Pir: The Great Saint of Cholistan
    Channer Pir: The Great Saint of Cholistan

    By Dr Asif Channer

  6. Literate the Religious Illiterate
    Literate the Religious Illiterate

    By Dr Asif Channer